Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.66
+0.33 (3.54%)
Nov 21, 2024, 1:24 PM EST - Market open

Immunome Statistics

Total Valuation

Immunome has a market cap or net worth of $602.95 million. The enterprise value is $344.94 million.

Market Cap 602.95M
Enterprise Value 344.94M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date Nov 13, 2024
Ex-Dividend Date n/a

Share Statistics

Immunome has 62.42 million shares outstanding. The number of shares has increased by 340.37% in one year.

Current Share Class 62.42M
Shares Outstanding 62.42M
Shares Change (YoY) +340.37%
Shares Change (QoQ) +0.45%
Owned by Insiders (%) 4.12%
Owned by Institutions (%) 73.63%
Float 45.38M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 49.40
Forward PS n/a
PB Ratio 2.62
P/TBV Ratio 2.72
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 34.05
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.17, with a Debt / Equity ratio of 0.01.

Current Ratio 6.17
Quick Ratio 6.07
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -276.36% and return on invested capital (ROIC) is -62.32%.

Return on Equity (ROE) -276.36%
Return on Assets (ROA) -39.89%
Return on Capital (ROIC) -62.32%
Revenue Per Employee $184,164
Profits Per Employee -$5.55M
Employee Count 55
Asset Turnover 0.06
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +16.77% in the last 52 weeks. The beta is 1.82, so Immunome's price volatility has been higher than the market average.

Beta (5Y) 1.82
52-Week Price Change +16.77%
50-Day Moving Average 12.81
200-Day Moving Average 16.05
Relative Strength Index (RSI) 28.05
Average Volume (20 Days) 755,980

Short Selling Information

The latest short interest is 10.47 million, so 16.77% of the outstanding shares have been sold short.

Short Interest 10.47M
Short Previous Month 10.92M
Short % of Shares Out 16.77%
Short % of Float 23.07%
Short Ratio (days to cover) 18.28

Income Statement

In the last 12 months, Immunome had revenue of $10.13 million and -$305.35 million in losses. Loss per share was -$5.69.

Revenue 10.13M
Gross Profit -81.00M
Operating Income -111.71M
Pretax Income -232.03M
Net Income -305.35M
EBITDA -110.44M
EBIT -111.71M
Loss Per Share -$5.69
Full Income Statement

Balance Sheet

The company has $240.13 million in cash and $2.72 million in debt, giving a net cash position of $237.41 million or $3.80 per share.

Cash & Cash Equivalents 240.13M
Total Debt 2.72M
Net Cash 237.41M
Net Cash Per Share $3.80
Equity (Book Value) 214.91M
Book Value Per Share 3.56
Working Capital 204.51M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$86.19 million and capital expenditures -$52.48 million, giving a free cash flow of -$138.68 million.

Operating Cash Flow -86.19M
Capital Expenditures -52.48M
Free Cash Flow -138.68M
FCF Per Share -$2.22
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,102.86%
Pretax Margin -3,014.59%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -361.11%

Dividends & Yields

Immunome does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -340.37%
Shareholder Yield -340.37%
Earnings Yield -52.29%
FCF Yield -23.75%

Analyst Forecast

The average price target for Immunome is $28.60, which is 196.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target $28.60
Price Target Difference 196.07%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 64.88%
EPS Growth Forecast (5Y) -53.89%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Immunome has an Altman Z-Score of 8.55 and a Piotroski F-Score of 2.

Altman Z-Score 8.55
Piotroski F-Score 2